Literature DB >> 8567540

Scaling for the VO2-to-body size relationship among children and adults.

D M Rogers1, B L Olson, J H Wilmore.   

Abstract

The purpose of this study was to examine the relationship between oxygen consumption (VO2) and both body surface area (BSA) and body size among 30 prepubertal children, 30 circumpubertal children, and 30 adults to determine which scaling model is most appropriate for making comparisons between these populations. All subjects participated in maximal treadmill testing and submaximal treadmill testing at two absolute work rates. Resting metabolic rate was measured on a subset of 48 subjects. It was determined that the submaximal VO2 (VO2 sm)-to-body size relationship provided the most appropriate model for comparisons. Analyses revealed a stronger linear relationship between VO2 sm and BSA than VO2 sm and body mass. Logarithmic transformation of the data revealed an allometric exponential relationship between VO2 sm and body mass. The exponent relating body mass to VO2 sm at 3 mph (1.34 m/s) was 0.60, whereas the exponent at 5 mph (2.24 m/s) was 0.75. VO2 values at 5 mph were significantly less variable (P < or = 0.05) than those at 3 mph. Therefore the exponent of body mass to the 0.75 power was considered a more appropriate basis for analysis. It was determined that, overall, a scaling factor of BSA or body mass to the 0.75 power both provide a more appropriate method of comparison than a simple ratio standard of body weight.

Entities:  

Mesh:

Year:  1995        PMID: 8567540     DOI: 10.1152/jappl.1995.79.3.958

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  22 in total

Review 1.  Endurance training and performance in runners: research limitations and unanswered questions.

Authors:  Kris Berg
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Effects of metabolic level on the body size scaling of metabolic rate in birds and mammals.

Authors:  Douglas S Glazier
Journal:  Proc Biol Sci       Date:  2008-06-22       Impact factor: 5.349

Review 3.  Strategies to improve running economy.

Authors:  Kyle R Barnes; Andrew E Kilding
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

4.  Hierarchical Linear Models for Energy Prediction using Inertial Sensors: A Comparative Study for Treadmill Walking.

Authors:  Harshvardhan Vathsangam; B Adar Emken; E Todd Schroeder; Donna Spruijt-Metz; Gaurav S Sukhatme
Journal:  J Ambient Intell Humaniz Comput       Date:  2013-12-01

5.  Cardiorespiratory fitness in pediatric renal transplant recipients.

Authors:  Christine B Sethna; Ann E Salerno; Michael G McBride; Justine Shults; Stephen M Paridon; Neha Sharma; Kevin E C Meyers; Mary B Leonard
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

6.  Peak circulatory power as an indicator of clinical status in children after Fontan procedure.

Authors:  Nitin Madan; Lisa Beachler; Pantelis Konstantinopoulos; Sarah Worley; Zhiyuan Sun; Larry A Latson
Journal:  Pediatr Cardiol       Date:  2010-10-19       Impact factor: 1.655

Review 7.  Cardiovascular responses to exercise in children.

Authors:  K R Turley
Journal:  Sports Med       Date:  1997-10       Impact factor: 11.136

Review 8.  Expression of VO2peak in Children and Youth, with Special Reference to Allometric Scaling.

Authors:  Mark Loftin; Melinda Sothern; Takashi Abe; Marc Bonis
Journal:  Sports Med       Date:  2016-10       Impact factor: 11.136

9.  Validation of the Innocor device for noninvasive measurement of oxygen consumption in children and adults.

Authors:  Shreya S Sheth; Dawn M Maxey; Alice E Drain; Jeffrey A Feinstein
Journal:  Pediatr Cardiol       Date:  2012-10-30       Impact factor: 1.655

10.  Decreased maximal aerobic capacity in pediatric chronic kidney disease.

Authors:  Donald J Weaver; Thomas R Kimball; Timothy Knilans; Wayne Mays; Sandra K Knecht; Yvette M Gerdes; Sandy Witt; Betty J Glascock; Janis Kartal; Philip Khoury; Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.